Considering different Montreal Cognitive Assessment cutoff scores for older adults with asthma
<b>Background:</b> There is a greater prevalence of cognitive impairment among ethnic and/or racial minorities, and cognitive impairment is a barrier to asthma self-management (SM) behaviors and outcomes in older adults. <b>Objective:</b> The aim of this study was to examine the relationship between cognitive impairment, assessed by using the Montreal Cognitive Assessment (MoCA), and asthma SM behaviors and outcomes in a sample of predominantly Black and Latino participants. In addition, we evaluated whether using two different MoCA cutoff scores influenced the association between cognitive impairment and asthma outcomes. <b>Methods:</b> Baseline cross-sectional data were extracted from a longitudinal study of older adults with asthma (N = 165) ages ≥60 years. Cognition was assessed by using the MoCA. Asthma Control Questionnaire, asthma-related quality of life (AQOL), and inhaled corticosteroid (ICS) adherence were assessed by using self-report. ICS dosing was collected through chart review and inhaler technique was observed and rated. <b>Results:</b> Using established MoCA cutoff scores of 23 and 26 yielded 45% and 74% cognitive impairment rates, respectively. Cognitive impairment, defined by using the cutoff score of 23, was significantly associated with worse asthma control (p = 0.04) and worse ICS adherence (p = 0.01). With a cutoff score of 26, only AQOL was significantly associated with cognitive impairment (p = 0.03). Race and/or ethnicity moderated the relationship between cognitive impairment and asthma control with a MoCA cutoff score of 23, and between cognitive impairment and AQOL with a MoCA cutoff score of 26. <b>Conclusion:</b> Cognitive impairment in older adults with asthma is associated with important clinical outcomes, but this relationship is influenced by the cutoff score used to define cognitive impairment.
Authors
- Alex D. Federman (ORCID: https://orcid.org/0000-0002-4824-064X)
- Sunit Jariwala (ORCID: https://orcid.org/0000-0001-6560-7418)
- Matthew Wysocki (ORCID: https://orcid.org/0000-0002-6622-3739)
- Gali Moritz (ORCID: https://orcid.org/0009-0001-9832-3558)
- Kimberly Arcoleo
- Juan P. Wisnivesky (ORCID: https://orcid.org/0000-0003-0299-4582)
- Roee Holtzer (ORCID: https://orcid.org/0000-0001-6639-0724)
- Paula J. Busse (ORCID: https://orcid.org/0000-0002-0793-2906)
- Jonathan M. Feldman (ORCID: https://orcid.org/0000-0002-7326-3026)
- Jyoti Ankam
- Jacqueline Becker (ORCID: https://orcid.org/0000-0003-2708-6046)
Institutions
- Albert Einstein College of Medicine (US)
- Montefiore Medical Center (US)
- Yeshiva University (US)
- Michigan State University (US)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- Allergy and Asthma Proceedings
- Published
- 2024-11-01
- DOI
- https://doi.org/10.2500/aap.2024.45.240045
- Citations
- 2
- Primary Topic
- Asthma and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.65